ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GA21255-1mg |
|
129696-23-7 |
Cecropin A (1-8)-Melittin (1-18) amide
|
0 | C136H233N33O29 | |
GA21254-5mg |
|
157606-25-2 |
Cecropin A (1-7)-Melittin A (2-9) amide
|
0 | C89H152N22O15 | |
GA21254-1mg |
|
157606-25-2 |
Cecropin A (1-7)-Melittin A (2-9) amide
|
0 | C89H152N22O15 | |
GA21253-1mg |
|
851538-67-5 |
Cdc25A (80-93) (human)
|
0 | C60H90N14O24S | |
GA21253-005mg |
|
851538-67-5 |
Cdc25A (80-93) (human)
|
0 | C60H90N14O24S | |
GA21252-5mg |
|
143257-75-4 |
CD36 (93-110)-Cys
|
0 | C96H151N29O33S | |
GA21252-1mg |
|
143257-75-4 |
CD36 (93-110)-Cys
|
0 | C96H151N29O33S | |
GA21251-5mg |
|
1351804-17-5 |
CBP501 Affinity Peptide
|
0 | C68H119N21O25S | |
GA21251-1mg |
|
1351804-17-5 |
CBP501 Affinity Peptide
|
0 | C68H119N21O25S | |
GA21250-5mg |
|
775289-20-8 |
Caspase-3/7 Inhibitor II
|
0 | C20H31N5O10 | |
GA21250-1mg |
|
775289-20-8 |
Caspase-3/7 Inhibitor II
|
0 | C20H31N5O10 | |
GA21249-1mg |
|
209615-75-8 |
CART (61-102) (human, rat)
|
0 | C189H310N58O56S7 | |
GA21249-005mg |
|
209615-75-8 |
CART (61-102) (human, rat)
|
0 | C189H310N58O56S7 | |
GA21249-001mg |
|
209615-75-8 |
CART (61-102) (human, rat)
|
0 | C189H310N58O56S7 | |
GA21248-1mg |
|
1815618-15-5 |
CART (55-76) (rat)
|
0 | C107H166N26O33S3 | |
GA21248-005mg |
|
1815618-15-5 |
CART (55-76) (rat)
|
0 | C107H166N26O33S3 | |
GA21247-500mg |
|
81109-85-5 |
Carboxymethyl-Phe-Leu-OH
|
0 | C17H24N2O5 | |
GA21247-100mg |
|
81109-85-5 |
Carboxymethyl-Phe-Leu-OH
|
0 | C17H24N2O5 | |
GA21246-5g |
|
77340-50-2 |
Carbamoyl-DL-Ala-OH
|
0 | C4H8N2O3 | |
GA21246-1g |
|
77340-50-2 |
Carbamoyl-DL-Ala-OH
|
0 | C4H8N2O3 | |